LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE FDC TABS

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

57 API Suppliers, 34 USDMF, 17 CEP/COS, 1 JDMF, 10 EU WC, 5 KDMF, 15 NDC API, 21 Listed Suppliers

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

520 FDF Dossiers, 127 FDA Orange Book, 201 Europe, 20 Canada, 13 Australia, 120 South Africa, 39 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 600MG BASE;EQ 50MG BASE;300MG, TABLET;ORAL - 150MG;200MG;300MG, TABLET;ORAL - 150MG, TABLET;ORAL - 300MG, TABLET;ORAL - 100MG;300MG;300MG, TABLET;ORAL - 300MG;300MG, TABLET;ORAL - EQ 600MG BASE;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 17 SPI Pharma, 8 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 Kirsch Pharma, 2 Cerata Pharmaceuticals LLP, 5 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 25 BASF, 8 Beneo, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 1 Gloria Interchem, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 19 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

74 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 41 Direct Compression, 35 Disintegrants & Superdisintegrants, 30 Granulation, 29 Thickeners and Stabilizers, 28 Solubilizers, 27 Controlled & Modified Release, 25 Taste Masking, 21 Chewable & Orodispersible Aids, 19 Parenteral, 18 Topical, 16 Co-Processed Excipients, 14 Lubricants & Glidants, 12 Film Formers & Plasticizers, 11 API Stability Enhancers, 8 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Rheology Modifiers, 2 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 105 News #PharmaBuzz

GLOBAL SALES INFORMATION

28 US Medicaid Prescriptions, 25 Regulatory FDF Prices, 35 Annual Reports

MARKET PLACE

16 APIs, 10 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents, 5 US Exclusivities, 44 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 USP, 7 Others

ANALYTICAL

1 BioAnalytical Methods, 1 Analytical Methods

Xls

Filters

FILTER :

filter Product Reset all filters

35 All

01 3Combivir

02 1Delstrigo

03 6Dovato

04 1Epzicom

05 6Epzicom/Kivexa

06 10Triumeq

07 3Trizivir

08 5Zeffix

01 Brand Name : Epzicom/Kivexa

Dolutegravir, Lamivudine

Arvo

Not Confirmed

02 Brand Name : Triumeq

Dolutegravir, Lamivudine

Arvo

Not Confirmed

03 Brand Name : Dovato

Dolutegravir, Lamivudine

AOCS Annual Meeting

Not Confirmed

04 Brand Name : Dovato

Dolutegravir, Lamivudine

Arvo

Not Confirmed

05 Brand Name : Triumeq

Dolutegravir, Lamivudine

Arvo

Not Confirmed

06 Brand Name : Dovato

Dolutegravir, Lamivudine

Arvo

Not Confirmed

07 Brand Name : Triumeq

Dolutegravir, Lamivudine

Arvo

Not Confirmed

08 Brand Name : Dovato

Dolutegravir, Lamivudine

Arvo

Not Confirmed

09 Brand Name : Triumeq

Dolutegravir, Lamivudine

Arvo

Not Confirmed

10 Brand Name : Dovato

Dolutegravir, Lamivudine

Arvo

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE FDC TABS

LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE FDC TABS

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

57 API Suppliers

34 USDMF

17 CEP/COS

1 JDMF

10 EU WC

5 KDMF

15 NDC API

21 Listed Suppliers

DEVELOPMENTS

29 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

520 FDF Dossiers

127 FDA Orange Book

201 Europe

20 Canada

13 Australia

120 South Africa

39 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 600MG BASE;EQ 50MG BASE;300MG

TABLET;ORAL - 150MG;200MG;300MG

TABLET;ORAL - 150MG

TABLET;ORAL - 300MG

TABLET;ORAL - 100MG;300MG;300MG

TABLET;ORAL - 300MG;300MG

TABLET;ORAL - EQ 600MG BASE;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc

17 SPI Pharma

8 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 Kirsch Pharma

2 Cerata Pharmaceuticals LLP

5 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

8 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

25 BASF

8 Beneo

1 Clariant

10 Corel Pharma Chem

6 DFE Pharma

1 Esteem Industries

2 Finar

12 Gangwal Chemicals

1 Gloria Interchem

5 Ideal Cures

4 Ingredion Pharma Solutions

26 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

19 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

TABLET;ORAL - EQ 600MG BASE;300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons